TABLE 1.
Demographics and baseline characteristics of enrolled patients with COVID‐19
| Patient | Gender | Age, year | Height, cm | Body weight, kg | BSA, kg/m2 | CKD‐EPI, ml/min/1.73 m2 | Serum albumin, g/dl | Renal function and replacement therapy |
|---|---|---|---|---|---|---|---|---|
| A | Male | 70 | 168 | 57.8 | 1.64 | 97.4 | 3.3 | Normal |
| B | Female | 36 | 159 | 75.6 | 1.83 | 120.3 | 3.3 | Normal |
| C | Male | 55 | 170 | 64.1 | 1.74 | 47.8 | 2.8 | Impaired renal function |
| D | Female | 85 | 150 | 46.7 | 1.39 | 31.0 | 3.2 | Impaired renal function |
| E | Male | 58 | 170 | 106.5 | 2.24 | 42.6 | 2.7 | Impaired renal function undergoing CRRT |
| F | Male | 81 | 171 | 54.7 | 1.61 | 40.1 | 2.9 | Impaired renal function undergoing CRRT |
| G | Male | 77 | 164 | 54.3 | 1.57 | 5.4 | 3.1 | Impaired renal function undergoing IHD |
| H | Male | 63 | 173 | 67.8 | 1.81 | 2.8 | 3.7 | Impaired renal function undergoing IHD |
| I | Male | 52 | 175 | 72.2 | 1.88 | 4.7 | 3.1 | Impaired renal function undergoing IHD |
Abbreviations: BSA, body surface area; CKD‐EPI, estimated glomerular filtration rate by the CKD‐EPI (Chronic Kidney Disease Epidemiology Collaboration) equation; COVID‐19, coronavirus disease 2019; CRRT, continuous renal replacement therapy; IHD, intermittent hemodialysis.